Viewing Study NCT03715933


Ignite Creation Date: 2025-12-25 @ 2:41 AM
Ignite Modification Date: 2026-03-13 @ 1:21 AM
Study NCT ID: NCT03715933
Status: RECRUITING
Last Update Posted: 2025-12-09
First Post: 2018-10-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Sponsor: Inhibrx Biosciences, Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module